Published in J Immunol on July 15, 1991
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat Immunol (2009) 1.98
Complement and the multifaceted functions of VWA and integrin I domains. Structure (2006) 1.22
New structural motifs on the chymotrypsin fold and their potential roles in complement factor B. EMBO J (2000) 0.99
The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. J Mol Biol (2006) 0.93
The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation. Acta Crystallogr D Biol Crystallogr (2009) 0.85
Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B. Biochem J (1999) 0.85
The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb. Structure (2009) 0.81
Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma-stimulated human fibroblasts, glioblastoma cell line A172 and monocytes. Biochem J (1995) 0.80
Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases. J Biol Chem (2016) 0.79
Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT. Biochem J (2005) 0.76
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med (1971) 3.32
Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res (2000) 2.80
The nucleotide sequence and protein-coding capability of the transposable element IS5. Gene (1981) 2.60
Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci U S A (1997) 2.59
Rabbit C1q: purification, functional and structural studies. J Immunol Methods (1972) 2.15
The nucleotide sequence of the chicken thymidine kinase gene and the relationship of its predicted polypeptide to that of the vaccinia virus thymidine kinase. Nucleic Acids Res (1984) 1.96
Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology (1999) 1.94
Three dimensional structure of human C-reactive protein. Nat Struct Biol (1996) 1.87
Adipsin and complement factor D activity: an immune-related defect in obesity. Science (1989) 1.87
Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect Immun (1989) 1.86
Conserved sequences at the origin of adenovirus DNA replication. J Virol (1982) 1.83
Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta (2001) 1.80
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice. J Immunol (1982) 1.77
Human papillomavirus DNA replication compartments in a transient DNA replication system. J Virol (1999) 1.76
Complement activation by C-reactive protein complexes. Ann N Y Acad Sci (1982) 1.75
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature (1979) 1.75
Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol (1974) 1.68
Regulation of sulfur assimilation in higher plants: a sulfate transporter induced in sulfate-starved roots plays a central role in Arabidopsis thaliana. Proc Natl Acad Sci U S A (1997) 1.67
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol (1995) 1.61
Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Infect Immun (1996) 1.60
Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59
The evolution of the adenoviral genome. Ann N Y Acad Sci (1980) 1.48
Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther (1995) 1.42
Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest (1977) 1.42
Blood clearance of Streptococcus pneumoniae by C-reactive protein. J Immunol (1987) 1.42
Unusual DNA structures in the adenovirus genome. J Biol Chem (1986) 1.38
Domains required for assembly of adenovirus type 2 fiber trimers. J Virol (1996) 1.35
Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts. J Virol (1998) 1.34
Human factor D of the alternative complement pathway: purification and characterization. J Immunol (1977) 1.33
Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J Biol Chem (2000) 1.31
Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Natl Acad Sci U S A (1989) 1.29
The structure of human lipoprotein A-I. Evidence for the "belt" model. J Biol Chem (1999) 1.28
Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry (1997) 1.25
Structural analysis of apolipoprotein A-I: effects of amino- and carboxy-terminal deletions on the lipid-free structure. Biochemistry (1998) 1.24
Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med (1998) 1.22
Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest (1992) 1.22
The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry (1998) 1.22
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement. J Immunol (1981) 1.22
The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virology (1991) 1.21
Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions. Immunochemistry (1976) 1.20
Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Ann Intern Med (1980) 1.19
Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro. J Virol (1993) 1.19
Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system. Biochem J (1993) 1.19
Characterization of the early region 3 and fiber genes of Ad7. Virology (1988) 1.18
Mutations of the precursor to the terminal protein of adenovirus serotypes 2 and 5. J Virol (1989) 1.18
C-reactive protein: structural biology, gene expression, and host defense function. Immunol Res (1997) 1.18
Nucleotide sequence of the genes encoded in early region 2b of human adenovirus type 12. Gene (1986) 1.17
Structure of human factor D. A complement system protein at 2.0 A resolution. J Mol Biol (1994) 1.17
Structures of native and complexed complement factor D: implications of the atypical His57 conformation and self-inhibitory loop in the regulation of specific serine protease activity. J Mol Biol (1998) 1.16
Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem (1993) 1.16
The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol (1992) 1.16
The Arthus reaction in rodents: species-specific requirement of complement. J Immunol (2000) 1.14
Expression of enzymatically active adenovirus DNA polymerase from cloned DNA requires sequences upstream of the main open reading frame. Virology (1987) 1.13
Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity. Clin Exp Immunol (1978) 1.12
Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins. J Virol (1990) 1.12
Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA. J Biol Chem (1990) 1.09
Stimulation of human neutrophil Fc receptor-mediated phagocytosis by a low molecular weight cytokine. J Immunol (1986) 1.09
Topology and structure of the C1q-binding site on C-reactive protein. J Immunol (2001) 1.08
C-reactive protein binding specificities: artificial and natural phospholipid bilayers. Ann N Y Acad Sci (1982) 1.08
Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D. EMBO J (1999) 1.07
Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--II. Effect of polyanions on the binding of C2 to EAC4b. Immunochemistry (1976) 1.07
Surface loops adjacent to the cation-binding site of the complement factor B von Willebrand factor type A module determine C3b binding specificity. Biochemistry (1997) 1.06
Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells. J Immunol (1985) 1.06
In vitro biosynthesis of complement protein D by U937 cells. J Immunol (1985) 1.05
Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol (1997) 1.04
Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates. J Biol Chem (1987) 1.04
Molecular genetics, structure, and function of C-reactive protein. Immunol Res (1991) 1.04
Recombinant and native zymogen forms of human complement factor D. J Immunol (1994) 1.04
The atypical serine proteases of the complement system. Adv Immunol (1998) 1.03
The structural basis for binding of complement by immunoglobulin M. J Exp Med (1974) 1.03
C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM. J Exp Med (1975) 1.03
Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods. Arthritis Rheum (1979) 1.01
Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba. J Immunol (1987) 1.01
Receptor mediated uptake of peptides that bind the human transferrin receptor. Eur J Biochem (2001) 1.01
Linker insertion mutations in the adenovirus preterminal protein that affect DNA replication activity in vivo and in vitro. J Virol (1991) 1.01
A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus. J Exp Med (1992) 1.01
Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. J Immunol Methods (1984) 1.00
Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta (2000) 1.00
Renal filtration and catabolism of complement protein D. N Engl J Med (1985) 0.99
New structural motifs on the chymotrypsin fold and their potential roles in complement factor B. EMBO J (2000) 0.99
Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol (1998) 0.98
Association of the human papillomavirus type 11 E1 protein with histone H1. J Virol (1998) 0.98
Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb. Biochemistry (1980) 0.98
The nucleotide sequence of the genes encoded in early region 2b of human adenovirus type 7. Gene (1983) 0.98
Mutagenesis of conserved region I in the DNA polymerase from human adenovirus serotype 2. Virology (1991) 0.98
Structural biology of the alternative pathway convertase. Immunol Rev (2001) 0.97
Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun (2000) 0.97
Cholera toxin and pertussis toxin regulate the Fc receptor-mediated phagocytic response of human neutrophils in a manner analogous to regulation by monoclonal antibody 1C2. J Immunol (1987) 0.96
cDNA cloning and expression of human complement component C2. J Immunol (1989) 0.96
Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infect Immun (1983) 0.96
Amino acid sequence of human D of the alternative complement pathway. Biochemistry (1984) 0.96
IgA deficiency. Immunodefic Rev (1991) 0.96